Blog

- DISEASE ADVANCES

Automated algorithm can detect cancer in blood samples in as little as 10 minutes

When cancer spreads, tiny amounts of cells can break away from tumors and circulate in the bloodstream. A liquid biopsy is a means to detect the presence of cancer by detecting these cancer cells floating in blood samples. However, current state-of-the-art methods have necessitated trained specialists to comb through and review images of thousands of cells out of potentially millions of cells on a slide over a period of many hours.

Read More »

FAU UNVEILS WORLD’S FIRST “BENCH-TO-BEDSIDE” MRI, FOCUSED ULTRASOUND PLATFORM TO ACCELERATE RESEARCH AND TREATMENT OF NEUROLOGICAL DISORDERS

Florida Atlantic University has expanded its NeuroInnovate Center, becoming the first institution globally to integrate advanced MRI and focused ultrasound technologies into a single, unified platform for both preclinical and clinical research. This breakthrough will accelerate the development of non-invasive treatments for neurological disorders such as Alzheimer’s, Parkinson’s and more.

Read More »

Simergent Announces FDA Clearance of the Archimedes™ Home Dialysis System

OKLAHOMA CITY and CHICAGO, Oct. 14, 2025 /PRNewswire/ — Simergent, a privately held company dedicated to advancing treatment for patients with kidney failure, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company’s Archimedes™ automated peritoneal dialysis (APD) system for the treatment of patients with End Stage Kidney Disease (ESKD) in clinical and home settings.

Read More »